PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
TI  - Vilazodone Effective and Safe in Major Depressive Disorder
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 13--14
VI  - 14
IP  - 8
4099  - http://mdc.sagepub.com/content/14/8/13.short
4100  - http://mdc.sagepub.com/content/14/8/13.full
AB  - A multicenter, randomized, double-blind, placebo-controlled trial involving more than 1100 patients with major depressive disorder has affirmed the efficacy and safety of vilazodone 40 mg/day and indicated the acceptability of a dose of 20 mg/day [APA 2014 (poster NR6-103)].